Local SME to mass-produce Sars-CoV-2 diagnostic test kits
LOCAL medtech firm MiRXES will take charge of mass-producing locally-developed diagnostic test kits for the novel coronavirus, as Singapore prepares to meet high levels of demand both locally and internationally for fast, accurate SARS-CoV-2 tests.
The diagnostic test kit was developed within just three weeks by the Agency for Science, Technology and Research (A*Star) and Tan Tock Seng Hospital, and has received provisional authorisation from the Health Sciences Authority. (see amendment note)
It uses the polymerase chain reaction (PCR) method to directly detect the pathogen that causes the Covid-19 disease, as opposed to other methods that detect antibodies produced in response to an infection, for instance. Singapore has sent 10,000 of these tests to China, and another 5,000 to local public hospitals.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
SMEs
Sun rising for Singapore businesses breaking into Japan market
One in three Singapore SMEs expect AI to replace or take over jobs: survey
Fintech KPay aims to triple Singapore merchant base, double local workforce
Singapore SMEs in contractionary mode for fifth straight quarter: OCBC
B2K’s second-generation leaders paw a new path in pet products
Finding a growth vector with digital solutions